BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 15118208)

  • 21. [Prevalence of HBV and HCV infections in plasma donors with recently increased ALT level].
    Li F
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):217-9. PubMed ID: 7511485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
    Irani-Hakime N; Musharrafieh U; Samaha H; Almawi WY
    Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The prevalence of hepatitis C antibodies among volunteer blood donors with elevated blood transaminase and antibodies to the B virus core antigen].
    Gavilán Carrasco JC; González Santos P; Rosario Díaz E
    Rev Clin Esp; 1996 May; 196(5):277-80. PubMed ID: 8768025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
    Bagga PK; Singh SP
    Indian J Pathol Microbiol; 2007 Apr; 50(2):429-32. PubMed ID: 17883101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voluntary donors-need for a second look.
    Kakkar N; Kaur R; Dhanoa J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):381-3. PubMed ID: 16295429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
    Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
    Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seropositivity for hepatitis B and C in voluntary blood donors.
    Shah SM; Khattak IU; Ali A; Tariq M
    J Ayub Med Coll Abbottabad; 2010; 22(3):149-51. PubMed ID: 22338442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic.
    Haidar NA
    Saudi Med J; 2002 Sep; 23(9):1090-4. PubMed ID: 12370719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
    Mutlu B; Meriç M; Willke A
    Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania].
    Lo BB; Meymouna M; Boulahi MA; Tew M; Sow A; Ba A; Sow MB
    Bull Soc Pathol Exot; 1999 May; 92(2):83-4. PubMed ID: 10399594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for the prevention of post-transfusion hepatitis.
    Mintz PD
    Ann Clin Lab Sci; 1984; 14(3):198-207. PubMed ID: 6428295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis B and C and blood donors.
    Mehdi SR; Pophali A; Al-Abdul Rahim KA
    Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors.
    Thakral B; Marwaha N; Chawla YK; Saluja K; Sharma A; Sharma RR; Minz RW; Agnihotri SK
    Indian J Med Res; 2006 Oct; 124(4):431-8. PubMed ID: 17159264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico].
    Ayala Gaytán JJ; Guerra Avalos FJ; Mora Brondo P; Casillas Romo A
    Rev Gastroenterol Mex; 1997; 62(4):250-3. PubMed ID: 9528294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
    Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
    J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.